Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Engstrom

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|May 25, 2010
Cancer of unknown primary siteGloria J Morris, Frank A Greco, John D Hainsworth, et al.
The Journal of Molecular Diagnostics : JMD|January 26, 2007
Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissueRenata A Coudry, Sibele I Meireles, Radka Stoyanova, et al.
Seminars in Urologic Oncology|February 6, 2002
Decision-making strategies for patients with localized prostate cancerMichael A Diefenbach, Jenevie Dorsey, Robert G Uzzo, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2021
Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasmsAlexander W MacFarlane, Ho-Man Yeung, R Katherine Alpaugh, et al.
American Journal of Clinical Oncology|April 1, 2008
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumorsSteven J Cohen, Paul F Engstrom, Nancy L Lewis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa regionFikri Içli, Hakan Akbulut, Shouki Bazarbashi, et al.
British Journal of Cancer|August 3, 2016
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot StudyNamrata Vijayvergia, Patrick M Boland, Elizabeth Handorf, et al.
Clinical Colorectal Cancer|August 24, 2011
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiativeMargaret A O'Grady, Elyse Slater, Elin R Sigurdson, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2002
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexedNancy L Lewis, Richard Scher, James M Gallo, et al.
JAMA Oncology|December 23, 2016
Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast CancerLisa A Newman, Azadeh Stark, Dhanajay Chitale, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|May 25, 2010
Cancer of unknown primary siteGloria J Morris, Frank A Greco, John D Hainsworth, et al.
The Journal of Molecular Diagnostics : JMD|January 26, 2007
Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissueRenata A Coudry, Sibele I Meireles, Radka Stoyanova, et al.
Seminars in Urologic Oncology|February 6, 2002
Decision-making strategies for patients with localized prostate cancerMichael A Diefenbach, Jenevie Dorsey, Robert G Uzzo, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2021
Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasmsAlexander W MacFarlane, Ho-Man Yeung, R Katherine Alpaugh, et al.
American Journal of Clinical Oncology|April 1, 2008
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumorsSteven J Cohen, Paul F Engstrom, Nancy L Lewis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa regionFikri Içli, Hakan Akbulut, Shouki Bazarbashi, et al.
British Journal of Cancer|August 3, 2016
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot StudyNamrata Vijayvergia, Patrick M Boland, Elizabeth Handorf, et al.
Clinical Colorectal Cancer|August 24, 2011
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiativeMargaret A O'Grady, Elyse Slater, Elin R Sigurdson, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2002
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexedNancy L Lewis, Richard Scher, James M Gallo, et al.
JAMA Oncology|December 23, 2016
Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast CancerLisa A Newman, Azadeh Stark, Dhanajay Chitale, et al.
Pageof 7